Compared with patients in the other groups, patients with PD who had a low plasma EV BDNF level (Q1) performed significantly worse in part II (daily activity) but not in part I (cognition and mood) or part III (motor symptoms as evaluated by an examiner) (Table 2). The gene discussed is BDNF; the disease is Parkinson disease.